Chronic Obstructive Pulmonary Disease (COPD) Archives - SafeGenericPharmacy-MY HEALTH PARTNER

Cart:

0 item(s) - $0.00
You have no items in your shopping cart.

0

OFEV® (nintedanib) Now Available in the United States

OFEV® (nintedanib) Now Available in the United States

Boehringer Ingelheim launches comprehensive support resources for people with idiopathic pulmonary fibrosis RIDGEFIELD, Conn., October 20, 2014 – Boehringer Ingelheim Pharmaceuticals, Inc. has announced that OFEV® (nintedanib) capsules are now commercially available in the United States. OFEV was approved by the U.S. Food and Drug Administration (FDA) on October 15, 2014 for the treatment of idiopathic pulmonary fibrosis (IPF). It is the only kinase inhibitor approved to treat IPF. IPF is a rare and fatal lung disease that affects as many as 132,000…

Chronic Obstructive Pulmonary Disease (COPD)

Chronic Obstructive Pulmonary Disease (COPD)

Overview   Chronic obstructive pulmonary disease (COPD) is a lung disorder that typically occurs in older adults with a history of smoking. It kills one person every four minutes in the United States and is one of the few causes of death that continues to increase. Today, more women than men have COPD, with an estimated 7 million women diagnosed with the disease. The prevalence of COPD is increasing among women while decreasing among men. Plus, more women than men…